Bessemer Group’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1
Closed 2738
2025
Q2
$0 Sell
1
-100
-99% -$5.44K ﹤0.01% 2639
2025
Q1
$6K Sell
101
-399
-80% -$23.9K ﹤0.01% 1973
2024
Q4
$31K Buy
+500
New +$32.3K ﹤0.01% 1379
2020
Q3
Sell
-13,200
Closed -$1.17M 1673
2020
Q2
$1.17M Buy
13,200
+300
+2% +$26.9K ﹤0.01% 697
2020
Q1
$1.21M Buy
12,900
+300
+2% +$27.9K ﹤0.01% 552
2019
Q4
$1.36M Buy
12,600
+200
+2% +$20.3K ﹤0.01% 680
2019
Q3
$1.19M Buy
12,400
+200
+2% +$18.6K ﹤0.01% 656
2019
Q2
$1.17M Buy
12,200
+400
+3% +$33.7K ﹤0.01% 674
2019
Q1
$1.04M Buy
11,800
+3,000
+34% +$264K ﹤0.01% 622
2018
Q4
$731K Buy
8,800
+1,500
+21% +$132K ﹤0.01% 650
2018
Q3
$688K Hold
7,300
﹤0.01% 677
2018
Q2
$804K Hold
7,300
﹤0.01% 628
2018
Q1
$722K Buy
7,300
+100
+1% +$8.92K ﹤0.01% 664
2017
Q4
$586K Sell
7,200
-500
-6% -$39K ﹤0.01% 766
2017
Q3
$566K Buy
7,700
+3,100
+67% +$223K ﹤0.01% 814
2017
Q2
$333K Buy
4,600
+1,300
+39% +$85.6K ﹤0.01% 951
2017
Q1
$206K Hold
3,300
﹤0.01% 1091
2016
Q4
$240K Buy
3,300
+1,400
+74% +$91K ﹤0.01% 1050
2016
Q3
$114K Buy
+1,900
New +$121K ﹤0.01% 1081

Other funds holding UTMD

Bessemer Group's UTMD Position: Q3 2025 in Review

Bessemer Group sold out of Utah Medical Products (UTMD) in Q3 2025, closing a stake of 1 share.

Bessemer Group first reported a position in UTMD in Q3 2016 and held it in 19 quarters. The position peaked at $1.36M in Q4 2019. 117 funds tracked by Wall St. Rank hold UTMD as of Q3 2025.

  • Bessemer Group reported no remaining Utah Medical Products position as of Q3 2025 after selling out during the quarter.
  • Bessemer Group sold 1 Utah Medical Products share in Q3 2025.
  • Bessemer Group first reported a position in Utah Medical Products in Q3 2016 and held it in 19 quarters.
  • Bessemer Group's Utah Medical Products position peaked at $1.36M in Q4 2019.
  • 117 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2025.

Based on Bessemer Group's 13F filing for Q3 2025, filed 5 Nov 2025.